Pages that link to "Q78169196"

The following pages link to Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis (Q78169196):

Displaying 31 items.

• Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury (Q27329908) (← links)
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases (Q28214190) (← links)
• High urine sIL-6R as a predictor of late graft failure in renal transplant recipients (Q33194234) (← links)
• Interactions of Neisseria gonorrhoeae with mature human macrophage opacity proteins influence production of proinflammatory cytokines. (Q34006551) (← links)
• Early differential expression of oncostatin M in obstructive nephropathy (Q34175664) (← links)
• Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis (Q34452035) (← links)
• Evaluation and management of pulmonary fibrosis in scleroderma (Q34560700) (← links)
• CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse (Q34792036) (← links)
• Interstitial lung disease in scleroderma (Q35169069) (← links)
• Cytokine regulation of pulmonary fibrosis in scleroderma (Q35561680) (← links)
• Pediatric scleroderma: systemic or localized forms (Q36282971) (← links)
• Signaling network of Oncostatin M pathway (Q36864673) (← links)
• The role of type 1 interferon in systemic sclerosis (Q37150404) (← links)
• Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited (Q37189391) (← links)
• The enigmatic cytokine oncostatin m and roles in disease (Q37409222) (← links)
• Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations (Q37453883) (← links)
• T cells in systemic sclerosis: a reappraisal (Q38009282) (← links)
• STAT3: a central mediator of pulmonary fibrosis? (Q38026814) (← links)
• Interleukin-6: a new therapeutic target in systemic sclerosis? (Q38288110) (← links)
• Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB. (Q39029262) (← links)
• Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells (Q39322803) (← links)
• Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases (Q40365292) (← links)
• Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement (Q40491920) (← links)
• Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? (Q41614290) (← links)
• Taxane-induced morphea in a patient with CREST syndrome (Q41938857) (← links)
• The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? (Q42607396) (← links)
• Angiopoietin-like protein 2 promotes inflammatory conditions in the ligamentum flavum in the pathogenesis of lumbar spinal canal stenosis by activating interleukin-6 expression. (Q53596185) (← links)
• Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response (Q54375228) (← links)
• Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts (Q60537818) (← links)
• Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study (Q84863206) (← links)
• Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes (Q89642055) (← links)